• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A comparative study of manganese meso-sulfonatophenyl porphyrins: contrast-enhancing agents for tumors.

作者信息

Fiel R J, Musser D A, Mark E H, Mazurchuk R, Alletto J J

机构信息

Department of Biophysics, Roswell Park Memorial Institute, Buffalo, New York 14263.

出版信息

Magn Reson Imaging. 1990;8(3):255-9. doi: 10.1016/0730-725x(90)90097-l.

DOI:10.1016/0730-725x(90)90097-l
PMID:2366638
Abstract

Four manganese meso-sulfonatophenyl porphyrins were prepared, characterized and investigated for their potential as tumor-specific MRI contrast-enhancing agents in mice bearing subcutaneous implants of a mammary carcinoma (SMT-F). The trisulfonated tetraphenyl porphyrin, MnTPPS3 presented the most favorable profile: bio-distribution, tumor concentration and tumor relaxivity, when compared at 24 hr postinjection. Imaging experiments revealed that a time-dependent delineation of tumor morphology occurs in response to MnTPPS3 that appears to correlate with necrotic regions of the tumor.

摘要

相似文献

1
A comparative study of manganese meso-sulfonatophenyl porphyrins: contrast-enhancing agents for tumors.
Magn Reson Imaging. 1990;8(3):255-9. doi: 10.1016/0730-725x(90)90097-l.
2
Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis.
Invest Radiol. 1997 Dec;32(12):770-9. doi: 10.1097/00004424-199712000-00008.
3
Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice.金属卟啉增强裸鼠人肿瘤异种移植模型的磁共振成像
Cancer Res. 1988 Aug 15;48(16):4604-10.
4
Tumor-selective contrast enhancing agent, Mn(III)meso- [tri(4-sulfonatophenyl)phenyl]porphine (MnTPPS3).肿瘤选择性造影剂,中- [三(4-磺基苯基)苯基]锰(III)卟啉(MnTPPS3)。
Magn Reson Imaging. 1993;11(7):1079-81. doi: 10.1016/0730-725x(93)90231-2.
5
MRI contrast-dose relationship of manganese(III)tetra(4-sulfonatophenyl) porphyrin with human xenograft tumors in nude mice at 2.0 T.2.0 T下锰(III)四(4-磺基苯基)卟啉与人裸鼠异种移植肿瘤的MRI造影剂剂量关系
Magn Reson Imaging. 1992;10(6):919-28. doi: 10.1016/0730-725x(92)90446-7.
6
Gadolinium-free extracellular MR contrast agent for tumor imaging.用于肿瘤成像的无钆细胞外磁共振造影剂。
J Magn Reson Imaging. 2015 Feb;41(2):397-403. doi: 10.1002/jmri.24561. Epub 2014 Jan 8.
7
Tissue distribution and stability of metalloporphyrin MRI contrast agents.
Magn Reson Med. 1987 Jan;4(1):24-33. doi: 10.1002/mrm.1910040104.
8
Mechanism of the localization of manganese (III) mesotetra(4-sulfonatophenyl)porphine in mice bearing L1210 tumors.中-四(4-磺酸苯基)卟吩锰(III)在携带L1210肿瘤小鼠体内的定位机制
Cancer Lett. 1988 May;40(1):23-32. doi: 10.1016/0304-3835(88)90258-3.
9
MnPcS4: a new MRI contrast enhancing agent for tumor localisation in mice.四磺基锰酞菁:一种用于小鼠肿瘤定位的新型磁共振成像造影增强剂。
Magn Reson Imaging. 1995;13(7):985-90. doi: 10.1016/0730-725x(95)00046-j.
10
Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice.金属卟啉在磁共振成像中对肿瘤的对比增强作用。对小鼠体内人癌、淋巴瘤和纤维肉瘤的研究。
Invest Radiol. 1987 Oct;22(10):822-8. doi: 10.1097/00004424-198710000-00009.

引用本文的文献

1
A Manganese Porphyrin Platform for the Design and Synthesis of Molecular and Targeted MRI Contrast Agents.锰卟啉平台用于设计和合成分子及靶向 MRI 对比剂。
Int J Mol Sci. 2023 May 31;24(11):9532. doi: 10.3390/ijms24119532.
2
Recent Advances in Photosensitizers as Multifunctional Theranostic Agents for Imaging-Guided Photodynamic Therapy of Cancer.近期用于癌症成像引导光动力治疗的多功能诊疗一体化光敏剂的研究进展。
Theranostics. 2021 Aug 26;11(18):9054-9088. doi: 10.7150/thno.62479. eCollection 2021.
3
Current trends in pyrrole and porphyrin-derived nanoscale materials for biomedical applications.
用于生物医学应用的吡咯和卟啉衍生纳米材料的当前趋势。
Nanomedicine (Lond). 2020 Oct;15(25):2493-2515. doi: 10.2217/nnm-2020-0125. Epub 2020 Sep 25.
4
Applications for Transition-Metal Chemistry in Contrast-Enhanced Magnetic Resonance Imaging.过渡金属化学在对比增强磁共振成像中的应用。
Inorg Chem. 2020 May 18;59(10):6648-6678. doi: 10.1021/acs.inorgchem.0c00510. Epub 2020 May 5.
5
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.磁共振成像对比剂的化学:当前的挑战与新前沿。
Chem Rev. 2019 Jan 23;119(2):957-1057. doi: 10.1021/acs.chemrev.8b00363. Epub 2018 Oct 16.
6
An overview on development and application of an experimental platform for quantitative cardiac imaging research in rabbit models of myocardial infarction.心肌梗死后兔模型定量心脏成像研究实验平台的开发与应用概述。
Quant Imaging Med Surg. 2014 Oct;4(5):358-75. doi: 10.3978/j.issn.2223-4292.2013.09.01.
7
Manganese(III) porphyrins complexed with P22 virus-like particles as T1-enhanced contrast agents for magnetic resonance imaging.锰(III)卟啉配合物与 P22 病毒样颗粒作为 T1 增强磁共振成像对比剂。
J Biol Inorg Chem. 2014 Feb;19(2):237-46. doi: 10.1007/s00775-013-1075-4. Epub 2013 Dec 21.
8
Manganese-based MRI contrast agents: past, present and future.基于锰的磁共振成像造影剂:过去、现在与未来。
Tetrahedron. 2011 Nov 4;67(44):8431-8444. doi: 10.1016/j.tet.2011.07.076.
9
Revisiting an old friend: manganese-based MRI contrast agents.重温旧友:锰基磁共振成像造影剂
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Mar-Apr;3(2):162-73. doi: 10.1002/wnan.116. Epub 2010 Sep 21.